Pheast Therapeutics, Inc.

About

Pheast Therapeutics, Inc. is a preclinical-stage biotechnology company focused on developing novel immuno-oncology therapies. The company is pioneering a new approach to cancer treatment by targeting innate immune evasion pathways, specifically harnessing the power of macrophages to recognize and eliminate cancer cells. Pheast's innovative approach aims to address the limitations of current immunotherapies and offer solutions for aggressive cancers.